Data / Drug companies / Dipharma Francis Srl
Dipharma Francis Srl: 72 products in the FDA NDC directory, labeler code 46438
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Dipharma Francis Srl (labeler code 46438) lists 72 products in the FDA National Drug Code Directory. By type: 72 bulk ingredients. Its main marketing category is bulk ingredients. The newest product started marketing on February 12, 2026.
The request: Watch Dipharma Francis Srl (FDA labeler code 46438): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 46438
- Products in commercial distribution
- 72
- Packages
- 76
- Finished drugs by generic name
- 0
- Prescription products
- 0
- Over the counter products
- 0
- Controlled substance products
- Schedule IV 3
- Started marketing in the last 12 months
- 2
- Earliest marketing start
- January 7, 1980
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Bulk ingredients | 72 | 100% |
Products by type
| Type | Products | Share |
|---|---|---|
| Bulk ingredients | 72 | 100% |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Powder | 70 | 97.2% |
| Liquid | 2 | 2.8% |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Sodium neridronate | 46438-0673 | Powder | Bulk ingredients | February 12, 2026 |
| Is5mn 90% lactose 200 10% | 46438-0672 | Powder | Bulk ingredients | February 12, 2026 |
| Migalastat hydrochloride | 46438-0674 | Powder | Bulk ingredients | July 29, 2025 |
| Miglustat milled | 46438-0671 | Powder | Bulk ingredients | December 10, 2024 |
| Miglustat | 46438-0665 | Powder | Bulk ingredients | December 10, 2024 |
| Cholic acid | 46438-0669 | Powder | Bulk ingredients | November 28, 2024 |
| Sapropterine dihydrochloride | 46438-0664 | Powder | Bulk ingredients | December 17, 2021 |
| Nytroglycerin solution | 46438-0663 | Liquid | Bulk ingredients | May 5, 2021 |
| Rufinamide | 46438-0662 | Powder | Bulk ingredients | April 15, 2021 |
| Rufinamide | 46438-0661 | Powder | Bulk ingredients | April 15, 2021 |
| Sapropterin dihydrochloride | 46438-0660 | Powder | Bulk ingredients | December 11, 2020 |
| Amitriptyline hydrochloride milled | 46438-0659 | Powder | Bulk ingredients | December 4, 2019 |
| Chenodeoxycholic acid | 46438-0657 | Powder | Bulk ingredients | September 1, 2019 |
| Crisaborole | 46438-0656 | Powder | Bulk ingredients | July 9, 2019 |
| Carglumic acid | 46438-0658 | Powder | Bulk ingredients | July 1, 2019 |
| Modafinil | 46438-0655 | Powder | Bulk ingredients | August 1, 2018 |
| Ursodiol | 46438-0653 | Powder | Bulk ingredients | August 1, 2018 |
| Fexofenadine hydrochloride | 46438-0651 | Powder | Bulk ingredients | August 1, 2018 |
| Tolbutamide | 46438-0650 | Powder | Bulk ingredients | August 1, 2018 |
| Dapsone micronized | 46438-0649 | Powder | Bulk ingredients | August 1, 2018 |
| 7-ketolithocholic acid | 46438-0646 | Powder | Bulk ingredients | August 1, 2018 |
| Dapsone | 46438-0645 | Powder | Bulk ingredients | August 1, 2018 |
| Modafinil | 46438-0102 | Powder | Bulk ingredients | August 1, 2018 |
| Tolbutamide | 46438-0002 | Powder | Bulk ingredients | August 1, 2018 |
| Bupropion hydrochloride | 46438-0647 | Powder | Bulk ingredients | December 1, 2016 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.